Magellan Health is a healthcare plans business based in the US. Magellan Health shares (MGLN) are listed on the NASDAQ and all prices are listed in US Dollars. Magellan Health employs 9,000 staff and has a trailing 12-month revenue of around $4.8 billion.
What's in this guide?
Our top picks for where to buy Magellan Health stock
How to buy Magellan Health stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – MGLN. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Magellan Health stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Magellan Health stock price (NASDAQ: MGLN)
Use our graph to track the performance of MGLN stocks over time.Magellan Health shares at a glance
Latest market close | $0.00 |
---|---|
52-week range | $0.00 - $0.00 |
50-day moving average | $94.68 |
200-day moving average | $94.47 |
Wall St. target price | $95.00 |
PE ratio | 8.4858 |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $11.19 |
Is it a good time to buy Magellan Health stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Magellan Health price performance over time
Historical closes compared with the close of $0 from 2022-01-19
1 week (2024-08-25) | nan% |
---|---|
1 month (2024-08-01) | nan% |
3 months (2024-06-01) | nan% |
6 months (2024-03-01) | nan% |
1 year (2023-09-01) | nan% |
---|---|
2 years (2022-09-01) | nan% |
3 years (2021-09-03) | 94.67 |
5 years (2019-09-05) | 61.6 |
Is Magellan Health stock undervalued or overvalued?
Valuing Magellan Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Magellan Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Magellan Health's P/E ratio
Magellan Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 8x. In other words, Magellan Health shares trade at around 8x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Magellan Health's PEG ratio
Magellan Health's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.93. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Magellan Health's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Magellan Health's EBITDA
Magellan Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $86.8 million.
The EBITDA is a measure of a Magellan Health's overall financial performance and is widely used to measure a its profitability.
Magellan Health financials
Revenue TTM | $4.8 billion |
---|---|
Operating margin TTM | 0.6% |
Gross profit TTM | $120.8 million |
Return on assets TTM | 0.54% |
Return on equity TTM | -0.16% |
Profit margin | 6.26% |
Book value | $73.44 |
Market Capitalization | $2.5 billion |
TTM: trailing 12 months
Magellan Health share dividends
We're not expecting Magellan Health to pay a dividend over the next 12 months.
Have Magellan Health's shares ever split?
Magellan Health's shares were split on a 1:308 basis on 5 January 2004. So if you had owned 308 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Magellan Health shares – just the quantity. However, indirectly, the new 30700% higher share price could have impacted the market appetite for Magellan Health shares which in turn could have impacted Magellan Health's share price.
Magellan Health share price volatility
Over the last 12 months, Magellan Health's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Magellan Health's is 1.0353. This would suggest that Magellan Health's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Magellan Health overview
Magellan Health, Inc. , together with its subsidiaries, provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans; and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. It also contracts with state Medicaid agencies, and the centers for Medicare and Medicaid services to manage care for beneficiaries under Medicaid and Medicare programs, such as healthcare and long-term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Further, it offers pharmacy benefit management services, such as pharmaceutical dispensing services; pharmacy benefit administration for state Medicaid and other government sponsored programs; clinical and formulary management programs; medical pharmacy management programs; and programs for the integrated management of specialty drugs that treat complex conditions.
Frequently asked questions
What percentage of Magellan Health is owned by insiders or institutions?Currently 1.644% of Magellan Health shares are held by insiders and 102.607% by institutions. How many people work for Magellan Health?
Latest data suggests 9,000 work at Magellan Health. When does the fiscal year end for Magellan Health?
Magellan Health's fiscal year ends in December. Where is Magellan Health based?
Magellan Health's address is: 4801 East Washington Street, Phoenix, AZ, United States, 85034 What is Magellan Health's ISIN number?
Magellan Health's international securities identification number is: US5590792074 What is Magellan Health's CUSIP number?
Magellan Health's Committee on Uniform Securities Identification Procedures number is: 161241708
More guides on Finder
-
Best options trading platforms of 2024
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
-
What is a covered call?
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
-
6 stocks like Nvidia you need to consider
Advanced Micro Devices (AMD), Intel Corporation (INTC) and Qualcomm Inc (QCOM) are top stocks like Nvidia. See our full list here.
-
GSD Capital review 2024
A look at GSD Capital’s highlights, limitations, fees and investment strategies.
-
Public vs. Robinhood
Compare pros, cons, research tools and reviews for these two trading platforms.
-
10 E*TRADE competitors worth your time
Looking for a discount broker like E*TRADE that offers something different? Here are some of the top alternatives to consider.
-
Charles Schwab vs. Fidelity
Charles Schwab and Fidelity are two powerhouse trading platforms for beginner and advanced investors.
-
Interactive Brokers review 2024: Tailored trading and investing
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
-
Top 15 tech stocks to invest in for 2024
Discover the top tech stocks poised to lead innovation and offer substantial growth opportunities.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Ask a question